Affiliation:
1. Department of Veterinary Medicine National Chiayi University Chiayi Taiwan
2. Department of Fishery Biology, Faculty of Fisheries Kasetsart University Bangkok Thailand
3. Department of Veterinary Medicine, College of Veterinary Medicine National Chung Hsing University Taichung Taiwan
Abstract
AbstractToltrazuril (TZR) is currently the only registered chemotherapeutic drug in the European Union for the treatment of Cystoisospora suis. This study investigated the comparative pharmacokinetics and tissue concentration‐time profiles of TZR and its active metabolite, toltrazuril sulfone (TZR‐SO2), after oral (per os, p.o.) and intramuscular (i.m.) administration to suckling piglets. Following a single administration of TZR orally at 50 mg/piglet or intramuscularly at 45 mg/piglet, higher concentrations of TZR and TZR‐SO2 were observed in all three investigated tissues after p.o. administration. The mean TZR concentration in serum peaked at 14 μg/mL (34.03 h) and 5.36 μg/mL (120 h), while TZR‐SO2 peaked at 14.12 μg/mL (246 h) and 9.92 μg/mL (330 h) after p.o. and i.m. administration, respectively. TZR was undetectable in the liver after p.o. administration (18 days) and in the jejunum (24 days) after i.m. injection, while TZR‐SO2 was still detectable in all three tissues after 36 days regardless of administration routes. This study showed that p.o. formulation exhibited faster absorption and higher serum/tissue TZR/TZR‐SO2 concentrations than i.m. formulation. Both formulations generated sufficient therapeutic concentrations in the serum and jejunum, and sustained enough time to protect against Cystoisospora suis infection in the piglets.
Subject
General Veterinary,Pharmacology
Reference29 articles.
1. An observational study on the prevalence and impact of Isospora suis in suckling piglets in southwestern Ontario, and risk factors for shedding oocysts;Aliaga‐Leyton A.;The Canadian Veterinary Journal,2011
2. EMA European Medicine Agency. (2000).Toltrazuril (extension to pigs) summary report (3).https://www.ema.europa.eu/en/documents/mrl‐report/toltrazuril‐extension‐pigs‐summary‐report‐3‐committee‐veterinary‐medicinal‐products_en.pdf
3. EMA European Medicine Agency. (2019).Forceris summary of opinion (initial authorization).https://www.ema.europa.eu/en/medicines/veterinary/EPAR/forceris
4. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review
5. Cystoisospora suis Control in Europe Is Not Always Effective
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Letter to the editor;Journal of Veterinary Pharmacology and Therapeutics;2023-11-10